Source comparison
MK-677 vs Growth Hormone Peptides: Protocol Comparison
The decision between MK-677 and traditional growth hormone secretagogues like Ipamorelin, Sermorelin, or CJC1295 Ipamorelin stacks depends on protocol goals, administration preference, and response profile. Below is a direct comparison across key research para
This comparison does not assign a generated winner or score.
- The decision between MK-677 and traditional growth hormone secretagogues like Ipamorelin, Sermorelin, or CJC1295 Ipamorelin stacks depends on protocol goals, administration preference, and response profile. Below is a direct comparison across key research parameters.
- Administration
- Oral (capsule or liquid)
- Subcutaneous injection daily
- Subcutaneous injection 1–2x/day
- MK-677 eliminates injection barriers. Critical for long-term adherence
- Dosing Frequency
- Once daily
- 1–3x daily (pulsatile dosing)
- Once daily (CJC) + 1–2x daily (Ipamorelin)
- MK-677 simplifies protocol compliance with single daily dose
- Half-Life
- ~24 hours
- ~2 hours
- ~6–8 days (CJC) / ~2 hours (Ipamorelin)
- MK-677 maintains stable plasma levels; peptides require precise timing
- Storage Requirements
- Room temperature stable
- Refrigeration required (2–8°C) post-reconstitution
- MK-677 has logistical advantage. No cold chain, no reconstitution
- IGF-1 Elevation
- 60–90% at 25mg daily
- 30–50% at 200–300mcg/day
- 80–120% (synergistic stack)
- CJC/Ipa stack produces highest IGF-1 but requires injection discipline
- Appetite Stimulation
- Pronounced (65–80% of users)
- Minimal
- Minimal to moderate
- MK-677 hunger response is the primary adherence challenge
- Cost (12-week protocol)
- Moderate
- Moderate to high
- High (dual compounds)
- MK-677 offers best cost-per-dose for oral-only protocols
- The bottom line: MK-677 is the most accessible entry point for growth hormone research. It removes injection barriers, simplifies storage, and delivers clinically meaningful IGF-1 elevation with once-daily dosing. But it's not universally superior. Researchers who can't manage the appetite stimulation or need higher IGF-1 ceilings achieve better results with CJC1295 Ipamorelin stacks despite the injection requirement.